Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Protara shares spike after bladder cancer data drop
Protara’s cell therapy elicited a 72% complete response rate for patients with bladder cancer, data that sent the biotech’s shares surging.
Gabrielle Masson
Dec 5, 2024 2:30pm
FDA chides Applied Therapeutics' trial conduct in warning letter
Dec 4, 2024 11:21am
GSK axes hepatitis B vaccine trial after missing efficacy goal
Dec 4, 2024 5:15am
Roivant’s midstage asset fails to show benefit in lung disease
Dec 3, 2024 10:32am
Outlook's eye disease drug fails to match Lucentis, sinking stock
Nov 27, 2024 8:40am
PTC axes utreloxastat program after phase 2 ALS failure
Nov 27, 2024 4:45am
